• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类基因组编辑未来的七个开放性问题。

Seven open questions in the futures of human genome editing.

作者信息

Nelson John P, Selin Cynthia L

机构信息

School for the Future of Innovation in Society, Arizona State University, 1120 South Cady Mall, Tempe, Arizona 85287-5603.

School for the Future of Innovation in Society/Consortium for Science, Policy & Outcomes, Arizona State University, 1120 South Cady Mall, Tempe, Arizona 85287-5603.

出版信息

Futures. 2023 May;149. doi: 10.1016/j.futures.2023.103138. Epub 2023 Mar 21.

DOI:10.1016/j.futures.2023.103138
PMID:37484876
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10358607/
Abstract

Scholarly discussion around the governance of human genome editing (HGE) recognizes that development and application of HGE techniques could result in unexpected societal outcomes. However, it contains few to no methodological models for how to anticipate, prepare for, or shape such outcomes. This article presents early-stage results from research guided by anticipatory governance, a framework for broad expert and public consideration of innovation processes and purposes. We present and discuss key themes emerging from a set of future-oriented interviews with genome editing practitioners and experts, designed to inform broadly scoped deliberations about plausible futures of HGE. We articulate our results as seven "open questions," the answers to which will be important components of HGE's eventual shape and outcomes. Some themes are perennial in studies of science and society, and others are more novel to HGE. Each helps to reframe HGE beyond a simple comparison of risk and benefit. Such reframing opens up new and important terrain for discussion among policymakers, academics, scientists, and publics. We suggest that discussion framed around broad and reflexive questions like those presented here will help governance efforts to better acknowledge and flexibly respond to the uncertainty and complexities of HGE developments.

摘要

围绕人类基因组编辑(HGE)治理的学术讨论认识到,HGE技术的开发和应用可能会导致意想不到的社会后果。然而,对于如何预测、应对或塑造这些后果,它几乎没有提供任何方法模型。本文展示了以预期治理为指导的研究的早期成果,预期治理是一个让专家和公众广泛参与对创新过程及目的进行考量的框架。我们展示并讨论了从一组面向未来的访谈中浮现出的关键主题,这些访谈对象包括基因组编辑从业者和专家,旨在为关于HGE可能未来的广泛审议提供信息。我们将研究结果归纳为七个“开放性问题”,这些问题的答案将是HGE最终形态和结果的重要组成部分。有些主题在科学与社会研究中一直存在,而其他一些主题对HGE来说则较为新颖。每个主题都有助于超越简单的风险与收益比较来重新审视HGE。这种重新审视为政策制定者、学者、科学家和公众之间的讨论开辟了新的重要领域。我们认为,围绕像本文所提出的这类广泛且具有反思性的问题展开讨论,将有助于治理工作更好地认识并灵活应对HGE发展中的不确定性和复杂性。

相似文献

1
Seven open questions in the futures of human genome editing.人类基因组编辑未来的七个开放性问题。
Futures. 2023 May;149. doi: 10.1016/j.futures.2023.103138. Epub 2023 Mar 21.
2
Toward Anticipatory Governance of Human Genome Editing: A Critical Review of Scholarly Governance Discourse.迈向人类基因组编辑的前瞻性治理:对学术治理话语的批判性审视
J Responsible Innov. 2021;8(3):382-420. doi: 10.1080/23299460.2021.1957579. Epub 2021 Jul 29.
3
Governing with public engagement: an anticipatory approach to human genome editing.通过公众参与进行治理:人类基因组编辑的前瞻性方法。
Sci Public Policy. 2024 Mar 25;51(4):680-691. doi: 10.1093/scipol/scae010. eCollection 2024 Aug.
4
An imbalanced approach to governance? An analysis of the WHO's position on human genome editing.失衡的治理之道?对世卫组织人类基因组编辑立场的分析。
Bioethics. 2023 Sep;37(7):656-661. doi: 10.1111/bioe.13193. Epub 2023 Jun 17.
5
Researching the future: scenarios to explore the future of human genome editing.研究未来:探索人类基因组编辑未来的情景。
BMC Med Ethics. 2023 Sep 21;24(1):72. doi: 10.1186/s12910-023-00951-8.
6
Steering vaccinomics innovations with anticipatory governance and participatory foresight.前瞻性治理和参与式预见引导疫苗学创新。
OMICS. 2011 Sep;15(9):637-46. doi: 10.1089/omi.2011.0087. Epub 2011 Aug 17.
7
Challenging the Boundaries Between Treatment, Prevention, and Enhancement in Human Genome Editing.在人类基因组编辑中挑战治疗、预防和增强之间的界限。
CRISPR J. 2024 Aug;7(4):180-187. doi: 10.1089/crispr.2024.0021. Epub 2024 Jul 8.
8
Heritable genome editing and cognitive biases: why broad societal consensus is the wrong standard for moving forward.可遗传的基因组编辑与认知偏差:为何广泛的社会共识并非推动前进的正确标准。
J Law Biosci. 2022 Feb 7;9(1):lsac002. doi: 10.1093/jlb/lsac002. eCollection 2022 Jan-Jun.
9
Human genome editing in clinical applications: Japanese lay and expert attitudes.临床应用中的人类基因组编辑:日本公众与专家的态度。
Front Genet. 2023 Aug 17;14:1205092. doi: 10.3389/fgene.2023.1205092. eCollection 2023.
10
Ethics and Global Governance of Human Germline Genome Editing: The Problem of Techno-Scientific Colonialist Paternalism.人类生殖系基因组编辑的伦理与全球治理:技术-科学殖民主义家长主义问题。
CRISPR J. 2020 Apr;3(2):83-88. doi: 10.1089/crispr.2019.0045.

引用本文的文献

1
Human Heritable Genome Editing and its Governance: Views of Scientists and Governance Professionals.人类可遗传基因组编辑及其治理:科学家和治理专业人士的观点
New Genet Soc. 2024;43(1). doi: 10.1080/14636778.2024.2404061. Epub 2024 Sep 20.
2
Governing with public engagement: an anticipatory approach to human genome editing.通过公众参与进行治理:人类基因组编辑的前瞻性方法。
Sci Public Policy. 2024 Mar 25;51(4):680-691. doi: 10.1093/scipol/scae010. eCollection 2024 Aug.
3
Anticipatory gaps challenge the public governance of heritable human genome editing.预期差距对可遗传人类基因组编辑的公共治理构成挑战。
J Med Ethics. 2025 Apr 24;51(5):jme-2023-109801. doi: 10.1136/jme-2023-109801.

本文引用的文献

1
Improve alignment of research policy and societal values.改善研究政策与社会价值观的一致性。
Science. 2020 Jul 3;369(6499):39-41. doi: 10.1126/science.abb3415.
2
A global observatory for gene editing.一个基因编辑全球观测站。
Nature. 2018 Mar;555(7697):435-437. doi: 10.1038/d41586-018-03270-w.
3
CRISPR'd babies: human germline genome editing in the 'He Jiankui affair'.基因编辑婴儿:“贺建奎事件”中的人类生殖系基因组编辑
J Law Biosci. 2019 Aug 13;6(1):111-183. doi: 10.1093/jlb/lsz010. eCollection 2019 Oct.
4
The Use and Misuse of in the CRISPR Debate.在 CRISPR 争论中对“编辑”的使用和滥用。
CRISPR J. 2019 Oct;2(5):316-323. doi: 10.1089/crispr.2019.0046.
5
A matter of life and longer life.事关生命和更长寿。
J Aging Stud. 2019 Sep;50:100800. doi: 10.1016/j.jaging.2019.100800. Epub 2019 Jul 19.
6
Characterizing Direct-to-Consumer Stem Cell Businesses in the Southwest United States.描述美国西南部的直接面向消费者的干细胞企业。
Stem Cell Reports. 2019 Aug 13;13(2):247-253. doi: 10.1016/j.stemcr.2019.07.001. Epub 2019 Aug 1.
7
Inside the circle of trust.在信任的圈子里。
Science. 2019 Aug 2;365(6452):430-437. doi: 10.1126/science.365.6452.430.
8
European Court of Justice delivers no justice to Europe on genome-edited crops.欧洲法院在基因编辑作物问题上未给欧洲带来公正。
Plant Biotechnol J. 2020 Jan;18(1):8-10. doi: 10.1111/pbi.13200. Epub 2019 Jul 22.
9
Is Enhancement the Price of Prevention in Human Gene Editing?在人类基因编辑中,强化是预防的代价吗?
CRISPR J. 2018 Dec;1(6):351-354. doi: 10.1089/crispr.2018.0040. Epub 2018 Nov 26.
10
Do CRISPR Germline Ethics Statements Cut It?CRISPR生殖系伦理声明可行吗?
CRISPR J. 2018 Apr;1(2):115-125. doi: 10.1089/crispr.2017.0024.